Nashville, Tenn., Sept. 3 -- The State of Tennessee Department Of Revenue (34717-01017) for Unclaimed Vehicle Portal. Description: The State is looking for a single, experienced vendor to implement ... Read More
U.S., July 7 -- ClinicalTrials.gov registry received information related to the study (NCT07683559) titled 'Extracorporeal Shock Wave Therapy in Patients With Lipedema' on June 23. Brief Summary: Lip... Read More
U.S., July 7 -- ClinicalTrials.gov registry received information related to the study (NCT07683598) titled 'DLBS1033 as Adjunctive Therapy for Patients With Diabetic Neuropathy' on June 18. Brief Sum... Read More
U.S., July 7 -- ClinicalTrials.gov registry received information related to the study (NCT07685912) titled 'Well-being Program for Caregivers of Patients With Advanced Cardiac and Pulmonary Disease' o... Read More
U.S., July 7 -- ClinicalTrials.gov registry received information related to the study (NCT07683585) titled 'Comparative Effectiveness of Dual Antihypertensive Regimens in Patients After Percutaneous C... Read More
U.S., July 7 -- ClinicalTrials.gov registry received information related to the study (NCT07682675) titled 'Study to Evaluate the Efficacy of Zanzalintinib in the Treatment of Relapsed or Metastatic A... Read More
U.S., July 7 -- ClinicalTrials.gov registry received information related to the study (NCT07683572) titled 'Device Validation of Augmented-Reality ICG Fluorescence Imaging for Sentinel Lymph Node Dete... Read More
U.S., July 7 -- ClinicalTrials.gov registry received information related to the study (NCT07685158) titled 'Relation Between Type of Scar Pregnancy and Number of Previous Cesarean Sections' on June 26... Read More
U.S., July 7 -- ClinicalTrials.gov registry received information related to the study (NCT07683754) titled 'T-DXd Based Therapy Followed by Endocrine Therapy Plus Dual HER2 Blockade in First-line HER2... Read More
U.S., July 7 -- ClinicalTrials.gov registry received information related to the study (NCT07682909) titled 'Prospective, Non-interventional, Multicenter Post-Market Clinical Follow-Up Study' on June 1... Read More